Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Ionis Pharmaceuticals Inc. (IONS)

60.13   -1.33 (-2.16%) 01-17 16:00
Open: 61.71 Pre. Close: 61.46
High: 61.78 Low: 59.93
Volume: 1,916,002 Market Cap: 8458M
Ionis Pharmaceuticals Inc is the RNA-targeted drug discovery and development company. Its broad pipeline consists of close to 32 drugs to treat a wide variety of diseases with an emphasis on cardiovascular, metabolic, severe, and rare diseases.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 61.912 - 62.284 62.284 - 62.56
Low: 59.049 - 59.538 59.538 - 59.902
Close: 59.491 - 60.209 60.209 - 60.743

Technical analysis

as of: 2020-01-17 4:37:17 PM
Stoxline posted a SELL today, upgraded from strong sell. Downward movement continues, but could change at any time.
Target: Six months: 74.24     One year: 77.34
Support: Support1: 59.25    Support2: 49.30
Resistance: Resistance1: 63.56    Resistance2: 66.22
Pivot: 61.51
Moving Average: MA(5): 61.97     MA(20): 61.57
MA(100): 60.62     MA(250): 65.29
MACD: MACD(12,26): 0.03     Signal(9): 0.15
Stochastic oscillator: %K(14,3): 38.64     %D(3): 55.80
RSI: RSI(14): 41.52
52-week: High: 86.58  Low: 53.34  Change(%): 4.7
Average Vol(K): 3-Month: 97245  10-Days: 89303

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
IONS has closed above bottom band by 18.9%. Bollinger Bands are 41.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to IONS's normal range. The bands have been in this narrow range for 7 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Empirico Announces Strategic Collaboration to Harness Human Genetics for the Discovery and Development of Novel Antisense Oligonucleotide Therapeutics
SAN DIEGO--(BUSINESS WIRE)-- #biologics--Empirico announces a strategic collaboration with Ionis Pharmaceuticals and the closing of its $17 million Series A-2 financing.

Ionis appoints Onaiza Cadoret-Manier as chief corporate development and commercial officer
CARLSBAD, Calif., Jan. 9, 2020 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS), the leader in RNA-targeted therapeutics, today announced the appointment of Onaiza Cadoret-Manier as chief corporate development and commercial officer reporting to Brett P. Monia, Ph.D., chief…

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 140.66
Shares Float (M) 127.94
% Held by Insiders 9.04
% Held by Institutions 87.72
Shares Short (K) 8670
Shares Short P. Month (K)

Stock Financials

EPS 3.030
Book Value (p.s.) 9.500
PEG Ratio 0.67
Profit Margin 52.35
Operating Margin 14.23
Return on Assets (ttm) 2.8
Return on Equity (ttm) 34.4
Qtrly Rev. Growth 15.5
Gross Profit (p.s.) 1.308
Sales Per Share
EBITDA (p.s.) 0.930
Qtrly Earnings Growth
Operating Cash Flow (M) 183.28
Levered Free Cash Flow (M) 130.15

Stock Valuations

P/E 19.84
P/E Growth Ratio -0.02
P/BV 6.33
P/S 10.20
P/CF 46.15

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.